InvestorsHub Logo
Followers 79
Posts 24502
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 10/21/2019 8:07:03 AM

Monday, October 21, 2019 8:07:03 AM

Post# of 27408
OPK - 2.095 Pre-market now at 2.51/2.58

OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

https://www.tradescores.com/StockReport/opk

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.